Lilly To Appeal Invalidity Ruling For Sun In Gemzar Suit

Law360, New York (November 2, 2009, 5:42 PM EST) -- Eli Lilly & Co. is appealing a federal court ruling that invalidated one of the patents in an infringement dispute with generic-drug maker Sun Pharmaceutical Industries Ltd. over the cancer treatment Gemzar.

The company filed a notice of appeal Friday indicating its plans to appeal the partial summary judgment ruling in favor of Sun to the U.S. Court of Appeals for the Federal Circuit. The district court agreed to issue final judgment on the issue Thursday.

The ruling at issue held that U.S. Patent Number 5,464,826,...
To view the full article, register now.